Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants

Virgilio P. Carnielli, Rosalia Da Riol, Giovanni Montini

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Aims - To determine whether iron supplementation would enhance erythropoiesis in preterm infants treated with high doses of human recombinant erythropoietin (r-HuEPO). Methods - Sixty three preterm infants were randomly allocated at birth to one of three groups to receive: r-HuEPO alone, 1200 IU/kg/week (EPO); or r-HuEPO and iron, 1200 IU/kg/week of r- HuEPO plus 20 mg/kg/week of intravenous iron (EPO+iron); or to serve as controls. All three groups received blood transfusions according to uniform guidelines. Results - Infants in the EPO+iron group needed fewer transfusions than controls - mean (95% CI) 1.0 (0.28-1.18) vs 2.9 (1.84-3.88) and received lower volumes of blood - mean (95% CI) 16.7 (4.9-28.6) vs 44.4 (29.0-59.7) ml/kg. The EPO group also needed lower volumes of blood than the controls- mean (95% CI) 20.1 (6.234.2) vs 44.4 (29.0-59.7) ml/kg, but the same number of transfusions, 1.3 (0.542.06) vs 2.9 (1.84-3.88). Reticulocyte and haematocrit values from postnatal weeks 5 to 8 were higher in the EPO+iron than in the EPO group, and both groups had higher values than the controls. Mean (SEM) plasma ferritin was lower in the EPO group - 65 (55) μg/l than in the EPO+iron group 780 (182) μg/l, and 561 (228) μg/l in the control infants. Conclusions - Early administration of high doses of r-HuEPO with iron supplements significantly reduced the need for blood transfusion. Intravenous iron (20 mg/kg/week in conjunction with r-HuEPO yielded a higher reticulocyte count and haematocrit concentration after the forth week of life than r-HuEPO alone. Infants treated with r-HuEPO alone showed signs of reduced iron stores.

Original languageEnglish
JournalArchives of Disease in Childhood: Fetal and Neonatal Edition
Volume79
Issue number1
Publication statusPublished - 1998

Fingerprint

Erythropoietin
Premature Infants
Iron
Blood Volume
Hematocrit
Blood Transfusion
Reticulocyte Count
Erythropoiesis
Reticulocytes
Ferritins
Parturition
Guidelines

Keywords

  • Anaemia of prematurity
  • Erythropoietin
  • Iron supplementation
  • Transfusion

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{c8ddb4b271b447fbb165acb76b4c01da,
title = "Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants",
abstract = "Aims - To determine whether iron supplementation would enhance erythropoiesis in preterm infants treated with high doses of human recombinant erythropoietin (r-HuEPO). Methods - Sixty three preterm infants were randomly allocated at birth to one of three groups to receive: r-HuEPO alone, 1200 IU/kg/week (EPO); or r-HuEPO and iron, 1200 IU/kg/week of r- HuEPO plus 20 mg/kg/week of intravenous iron (EPO+iron); or to serve as controls. All three groups received blood transfusions according to uniform guidelines. Results - Infants in the EPO+iron group needed fewer transfusions than controls - mean (95{\%} CI) 1.0 (0.28-1.18) vs 2.9 (1.84-3.88) and received lower volumes of blood - mean (95{\%} CI) 16.7 (4.9-28.6) vs 44.4 (29.0-59.7) ml/kg. The EPO group also needed lower volumes of blood than the controls- mean (95{\%} CI) 20.1 (6.234.2) vs 44.4 (29.0-59.7) ml/kg, but the same number of transfusions, 1.3 (0.542.06) vs 2.9 (1.84-3.88). Reticulocyte and haematocrit values from postnatal weeks 5 to 8 were higher in the EPO+iron than in the EPO group, and both groups had higher values than the controls. Mean (SEM) plasma ferritin was lower in the EPO group - 65 (55) μg/l than in the EPO+iron group 780 (182) μg/l, and 561 (228) μg/l in the control infants. Conclusions - Early administration of high doses of r-HuEPO with iron supplements significantly reduced the need for blood transfusion. Intravenous iron (20 mg/kg/week in conjunction with r-HuEPO yielded a higher reticulocyte count and haematocrit concentration after the forth week of life than r-HuEPO alone. Infants treated with r-HuEPO alone showed signs of reduced iron stores.",
keywords = "Anaemia of prematurity, Erythropoietin, Iron supplementation, Transfusion",
author = "Carnielli, {Virgilio P.} and {Da Riol}, Rosalia and Giovanni Montini",
year = "1998",
language = "English",
volume = "79",
journal = "Archives of Disease in Childhood: Fetal and Neonatal Edition",
issn = "1359-2998",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants

AU - Carnielli, Virgilio P.

AU - Da Riol, Rosalia

AU - Montini, Giovanni

PY - 1998

Y1 - 1998

N2 - Aims - To determine whether iron supplementation would enhance erythropoiesis in preterm infants treated with high doses of human recombinant erythropoietin (r-HuEPO). Methods - Sixty three preterm infants were randomly allocated at birth to one of three groups to receive: r-HuEPO alone, 1200 IU/kg/week (EPO); or r-HuEPO and iron, 1200 IU/kg/week of r- HuEPO plus 20 mg/kg/week of intravenous iron (EPO+iron); or to serve as controls. All three groups received blood transfusions according to uniform guidelines. Results - Infants in the EPO+iron group needed fewer transfusions than controls - mean (95% CI) 1.0 (0.28-1.18) vs 2.9 (1.84-3.88) and received lower volumes of blood - mean (95% CI) 16.7 (4.9-28.6) vs 44.4 (29.0-59.7) ml/kg. The EPO group also needed lower volumes of blood than the controls- mean (95% CI) 20.1 (6.234.2) vs 44.4 (29.0-59.7) ml/kg, but the same number of transfusions, 1.3 (0.542.06) vs 2.9 (1.84-3.88). Reticulocyte and haematocrit values from postnatal weeks 5 to 8 were higher in the EPO+iron than in the EPO group, and both groups had higher values than the controls. Mean (SEM) plasma ferritin was lower in the EPO group - 65 (55) μg/l than in the EPO+iron group 780 (182) μg/l, and 561 (228) μg/l in the control infants. Conclusions - Early administration of high doses of r-HuEPO with iron supplements significantly reduced the need for blood transfusion. Intravenous iron (20 mg/kg/week in conjunction with r-HuEPO yielded a higher reticulocyte count and haematocrit concentration after the forth week of life than r-HuEPO alone. Infants treated with r-HuEPO alone showed signs of reduced iron stores.

AB - Aims - To determine whether iron supplementation would enhance erythropoiesis in preterm infants treated with high doses of human recombinant erythropoietin (r-HuEPO). Methods - Sixty three preterm infants were randomly allocated at birth to one of three groups to receive: r-HuEPO alone, 1200 IU/kg/week (EPO); or r-HuEPO and iron, 1200 IU/kg/week of r- HuEPO plus 20 mg/kg/week of intravenous iron (EPO+iron); or to serve as controls. All three groups received blood transfusions according to uniform guidelines. Results - Infants in the EPO+iron group needed fewer transfusions than controls - mean (95% CI) 1.0 (0.28-1.18) vs 2.9 (1.84-3.88) and received lower volumes of blood - mean (95% CI) 16.7 (4.9-28.6) vs 44.4 (29.0-59.7) ml/kg. The EPO group also needed lower volumes of blood than the controls- mean (95% CI) 20.1 (6.234.2) vs 44.4 (29.0-59.7) ml/kg, but the same number of transfusions, 1.3 (0.542.06) vs 2.9 (1.84-3.88). Reticulocyte and haematocrit values from postnatal weeks 5 to 8 were higher in the EPO+iron than in the EPO group, and both groups had higher values than the controls. Mean (SEM) plasma ferritin was lower in the EPO group - 65 (55) μg/l than in the EPO+iron group 780 (182) μg/l, and 561 (228) μg/l in the control infants. Conclusions - Early administration of high doses of r-HuEPO with iron supplements significantly reduced the need for blood transfusion. Intravenous iron (20 mg/kg/week in conjunction with r-HuEPO yielded a higher reticulocyte count and haematocrit concentration after the forth week of life than r-HuEPO alone. Infants treated with r-HuEPO alone showed signs of reduced iron stores.

KW - Anaemia of prematurity

KW - Erythropoietin

KW - Iron supplementation

KW - Transfusion

UR - http://www.scopus.com/inward/record.url?scp=0031852009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031852009&partnerID=8YFLogxK

M3 - Article

VL - 79

JO - Archives of Disease in Childhood: Fetal and Neonatal Edition

JF - Archives of Disease in Childhood: Fetal and Neonatal Edition

SN - 1359-2998

IS - 1

ER -